Cytokines and platelet-activating factor in human inflamed colonic mucosa

D. Rachmilewitz*, R. Eliakim, P. Simon, M. Ligumsky, F. Karmeli

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Colonic biopsy specimens from patients with active ulcerative colitis and controls were incubated for four hours in the presence or absence of calcium ionophore or antihuman immunoglobulin E (IgE). Platelet-activating factor (PAF) was determined in the tissue by aggregation assay after extraction with 80% ethanol. PAF was not detected in normal mucosa, whereas A23187 and antihuman IgE stimulated its activity: mean ±SE, 43.2±8.6 and 33.0±6.1 pg/10 mg wet weight, respectively. In active ulcerative colitis, A23187 and antihuman IgE induced significantly higher stimulation of PAF synthesis compared to their effects on normal mucosa. The enhanced stimulation of PAF induced by A23187 was dose-dependently inhibited by sulphazalazine, 5-aminosalicylic acid and prednisolone, but not by sulfapyridine. Colonic interleukin-1 content and release during 24 h of culture were significantly higher in patients with active ulcerative colitis and Crohn's disease compared to normal subjects. Prednisolone significantly and dose-dependently inhibited interleukin-1 release. These results suggest that colonic generation of PAF and interleukin-1 are elevated in patients with inflammatory bowel disease and, thus, may have a role in its pathogenesis. Pharmacological suppression of colonic PAF and interleukin-1 production may have beneficial therapeutic effects.

Original languageEnglish
Pages (from-to)C32-C36
JournalAgents and Actions
Issue number1 Supplement
StatePublished - Mar 1992
Externally publishedYes


Dive into the research topics of 'Cytokines and platelet-activating factor in human inflamed colonic mucosa'. Together they form a unique fingerprint.

Cite this